The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Bim and soluble PD-L1 (sPD-L1) as predictive biomarkers of response to anti-PD-1 therapy in patients with melanoma and lung carcinoma.
 
Roxana Stefania Dronca
Research Funding - Merck Sharp & Dohme (Inst)
Other Relationship - Elsevier
 
Aaron Scott Mansfield
Consulting or Advisory Role - Celgene; Genentech (Inst); Trovagene
Travel, Accommodations, Expenses - Celgene; Rockpointe; Trovagene
 
Xin Liu
No Relationships to Disclose
 
Susan Harrington
No Relationships to Disclose
 
Elizabeth Ann Enninga
No Relationships to Disclose
 
Lisa A. Kottschade
Consulting or Advisory Role - Merck (Inst); Novartis
 
Chi Wan Koo
No Relationships to Disclose
 
Robert R. McWilliams
Consulting or Advisory Role - Merrimack (Inst)
Research Funding - Aduro Biotech (Inst); Genentech (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); PRISM BioLab (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Matthew Stephen Block
Research Funding - Immune Design (Inst); TapImmune Inc. (Inst)
 
Wendy Kay Nevala
No Relationships to Disclose
 
Svetomir Markovic
Research Funding - Celgene; Novartis
 
Haidong Dong
No Relationships to Disclose